Breast carcinoma in men

  title={Breast carcinoma in men},
  author={Sharon H. Giordano and Deborah S. Cohen and Aman U. Buzdar and George H. Perkins and Gabriel N. Hortobagyi},
Male breast carcinoma is an uncommon disease, and most previous studies have been single‐institution series that were limited by extremely small sample sizes. The goals of the current study were to fill in the major gaps in knowledge regarding the incidence, presenting characteristics, prognostic factors, and survival rates of male breast carcinoma and to determine how breast carcinoma differs between men and women. 

Male breast carcinoma and review of the literature

Male breast cancer is a rare disease with unclear etiology and usually, these male patients present in advance stages due to non-specific clinical features and due to lack of awareness.

Papillary Carcinoma of Male Breast: The Uncommon Pathology of Breast Cancer

Papillary carcinoma of breast is an extremely rare form of breast cancer that tends to affect older age group but had excellent prognosis.

Metastatic male breast cancer

Male breast cancer is treated like female breast cancer and the outcome of the disease is  worse, 5-4 year’s survival in about 40% cases.

Male Breast Carcinoma – A Cytological Study & Clinicopathological Correlation of a Case

A case of male breast cancer diagnosed with cytology in a 73 year old male patient is presented to highlight its rarity and to increase the awareness.

Synchronous bilateral breast cancer in a male

A 70-year-old male patient with bilateral multifocal and synchronous breast cancer and without a family history of breast cancer is reported on.

Male breast cancer, clinical presentation, diagnosis and treatment: Twenty years of experience in our Breast Unit

Breast Cancer in Men: Oncology

Genetic factors are among the most clearly established risk factors for male breast cancer, and mainly involve BRCA1 and BRCa2 tumor-suppressor genes.


An 82 year-old male patient who had pain and swelling in his left breast for about 3 years and had lung and liver metastasis is presented, hoping that the importance of early diagnosis of male breast cancer will be emphasized.

Male breast cancer: a Singapore perspective

This study aims to report the institutional experience of MBC across a 20 year period, analyse the survival outcome and prognosis of this group against female breast cancer patients treated at the same centre, and treatment recommendations have been extrapolated from trial data of female breast cancers patients.

Male Breast Cancer in a Young Patient Treated with Nipple-Sparing Mastectomy: Case Report and Review of the Literature

A case of male breast carcinoma in a young patient (44 years of age), which is quite unusual in the pattern of breast carcinomas presentation is described.



Carcinoma of the breast in males

Cases of breast carcinoma in males were accrued from multiple hospitals in one region to determine treatment, survival, and prognostic factors.

The prognosis of breast cancer in males a report of 335 cases

No studies of male patients with breast cancer have presented survival information based on the number of histologically positive axillary nodes, the most sensitive single indicator of prognosis in women with breastcancer.

[Male breast cancer].

There are about 350 men diagnosed each year in the UK, compared with around 50,000 cases of breast cancer in women; the incidence of male breast cancer has increased over a period of 25 years.

Cancer in the male breast

A current and unselected group of cases diagnosed at any U.S. Air Force hospital from 1957 to 1972 shows that, unlike the general impression, the prognosis is neither abysmal nor aggravated by delay in the institution of therapy.

Male breast carcinoma

A single‐institution review of clinical presentation, treatment, and outcome of male breast carcinoma was conducted.

Racial/ethnic differences in survival rates in a population‐based series of men with breast carcinoma †

A rare occurrence, about 1500 men in the United States develop breast carcinoma each year. Little is known about survival patterns at the population level, particularly about racial/ethnic variation.

Estrogen receptors in male breast cancer: Clinical and pathologic correlations

Breast cancer tissue from 12 male patients was evaluated for the presence of estrogen receptors (ER), and at least 10 of 12 were found to be high in ER (ER +), and Measurement of ER may be clinically important in men with breast cancer.

Male Breast Cancer: A Clinicopathologic Study of 97 Cases

Comparison with a series of 304 women with breast cancer operated on at Memorial Hospital in 1960 revealed no difference with regard to incidence of positive axillary lymph nodes or stage of disease, there was, however, a significantly lower survival rate for men.

Breast cancer in the male: A report of 138 cases

This is a report of 138 male patients with cancer of the breast who were treated at the Hellenic Anticancer Institute from 1937 to 1974, finding that there were no 5-year survivors among patients treated with a combination of radiotherapy, chemotherapy, and hormonal manipulation.